This website is a global information resource. It is intended for healthcare professionals outside of the United States of America (US) and the United Kingdom (UK) who are interested in information on PiaSky®. This website is not country-specific and therefore may contain information which is not applicable to your country. Please refer to your local Prescribing Information for full details.
Body Weight40 kg to <100 kg≥100 kg |
|---|
|
Loading Dose |
|
Day 1 1000 mg (IV) 1500 mg (IV) |
|
Day 2, 8, 15, 22 340 mg (SC) 340 mg (SC) |
|
Maintenance Dose |
|
Day 29 and Q4W thereafter 680 mg (SC) 1020 mg (SC) |
Dosing & Administration
How to train your patients or their caregivers to prepare and administer subcutaneous injections for PiaSky®
The initial PiaSky® loading dose is an IV infusion, administered by a healthcare provider.1
*Patients starting PiaSky® will receive an initial weight-based loading dose through IV infusion. Four subsequent loading doses are then given weekly by subcutaneous injection. Weight-based maintenance dosing is then administered once every 4 weeks subcutaneously. Patients may self-inject after receiving training from their healthcare provider.
IV = intravenous; Q4W = 4-weekly; SC = subcutaneous.